Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Gore Range Capital is a specialized healthcare investment firm founded in 2015 and headquartered in New York. The firm focuses on building science-led platforms across various sectors, including precision health, regenerative medicine, personalized therapeutics, longevity, and restorative medical sciences. By integrating the operational discipline of private equity with the scientific partnership model of venture investing, Gore Range Capital works closely with its portfolio companies to provide strategic, financial, and clinical guidance.
As of now, Gore Range Capital manages a diverse portfolio and has made significant strides in the healthcare investment landscape. The firm primarily operates in North America and has established a reputation for its targeted approach to investing in next-generation healthcare solutions. Notable milestones include the successful sale of Novaestiq Corp. to Waldencast, showcasing the firm's ability to identify and nurture high-potential companies.
Gore Range Capital invests in companies that are developing next-generation healthcare solutions aimed at addressing the root causes of aging, chronic disease, and functional decline. The firm emphasizes innovations that integrate scientific discovery with clinical and commercial scalability. A key area of focus is the skin, which serves as a biological gateway to health and longevity. The firm seeks to support technologies and therapies that begin with clinically accessible biological systems and expand into broader healthcare applications.
Investment stages include seed, Series A, Series B, and growth equity, allowing Gore Range Capital to engage with companies at various points in their development. The firm is particularly interested in biotech, healthcare, and longevity sectors, targeting innovations that promise to revolutionize patient care and improve health outcomes.
Gore Range Capital has a notable portfolio that includes several companies making significant advancements in healthcare. Key portfolio companies include:
These companies exemplify Gore Range Capital's strategy of investing in healthcare solutions that tackle critical issues related to aging and chronic diseases.
Ethan Rigel - Managing Partner. Ethan has extensive experience in healthcare investments and has led numerous successful deals in the sector.
Ting Pau Oei - Venture Partner. Ting brings a wealth of knowledge in biotech and healthcare, having worked with various startups in the industry.
Humberto Antunes - Partner. Humberto has a strong background in operational management and has been instrumental in guiding portfolio companies.
Chidi Nwankpa, MD, MBA - Principal. Chidi combines medical expertise with business acumen, focusing on innovative healthcare solutions.
Matt Leavitt, DO, FAAD - Executive Partner. Matt has a deep understanding of dermatology and its intersection with healthcare innovation.
John Freidman - Senior Advisor. John provides strategic insights based on his extensive experience in healthcare investments.
Lloyd Appel - Chief Financial Officer. Lloyd oversees the financial operations of the firm, ensuring sound fiscal management.
Additionally, the Scientific Advisory Board includes notable experts such as Darrell Rigel, MD, FAAD (Advisory Board Chair), April W. Armstrong, MD, FAAD, MPH, Neal Bhatia, MD, FAAD, Seemal R Desai, MD, FAAD, Lawrence Kauvar, PhD, Richard D. Granstein, MD, FAAD, Joel L. Cohen, MD, FAAD, Aaron S. Farberg, MD, FAAD, and Gary Goldenberg, MD, FAAD, who provide scientific guidance and insights to the firm.
To pitch Gore Range Capital, founders should visit their website at gorerangecapital.com. The firm prefers detailed pitch decks that include information on the technology, market opportunity, competitive landscape, and team qualifications. A warm introduction is beneficial but not mandatory. Response times can vary, so founders should be prepared for potential follow-up discussions.
In recent months, Gore Range Capital has been active in notable transactions and clinical developments within its portfolio. The firm successfully facilitated the sale of Novaestiq Corp. to Waldencast, marking a significant exit.
Additionally, Eirion Therapeutics is currently involved in a clinical trial for a potential breakthrough treatment for hair loss, demonstrating the firm's commitment to supporting innovative healthcare solutions. Furthermore, Palvella Therapeutics received a grant from the U.S. Food and Drug Administration for its work in orphan products development, highlighting the firm's focus on addressing unmet medical needs.
What are Gore Range Capital's investment criteria?
Gore Range Capital focuses on companies developing next-generation healthcare solutions that address the root causes of aging, chronic disease, and functional decline. They look for innovations that integrate scientific discovery with clinical and commercial scalability.
How can I apply or pitch to Gore Range Capital?
Founders can pitch their ideas through the firm's website at gorerangecapital.com. It is advisable to include a detailed overview of the technology, market potential, and team background in the pitch deck.
What makes Gore Range Capital different from other investors?
The firm combines the operational discipline of private equity with the scientific partnership model of venture investing, providing strategic, financial, and clinical guidance to its portfolio companies.
What is the geographic scope of Gore Range Capital's investments?
Gore Range Capital primarily invests in North America, focusing on companies that are innovating in the healthcare sector.
What is the typical check size for investments?
While specific check sizes are not disclosed, Gore Range Capital invests at various stages, including seed, Series A, Series B, and growth equity, indicating a flexible approach to funding.
What kind of post-investment involvement can founders expect?
Gore Range Capital actively engages with its portfolio companies, providing strategic, financial, and clinical guidance to help them scale and succeed in the market.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.